249A — Human Adjust Co Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Human Adjust Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho |
| Standards: | JAS | JAS | — |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 1,374 | 1,953 | 2,558 |
| Cost of Revenue | |||
| Gross Profit | 374 | 659 | 890 |
| Selling / General / Administrative Expenses | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 1,448 | 1,900 | 2,329 |
| Operating Profit | -73.2 | 52.8 | 230 |
| Gain / Loss on Sale of Assets | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -54.8 | 45 | 211 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -34.9 | 27.8 | 150 |
| Net Income Before Extraordinary Items | |||
| Net Income | -34.9 | 27.8 | 150 |
| Adjustments to Net Income | |||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -34.9 | 27.8 | 150 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -91.8 | 136 | 595 |
| Dividends per Share |